Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Dantrolene Sodium Salt: Calcium Research Workflows
2026-10-01
Dantrolene sodium salt provides a mechanism-focused way to probe ryanodine receptor activity, intracellular calcium release, and calmodulin-dependent signaling. This practical guide connects calcium imaging, pancreatitis and neurodegeneration models, and carefully controlled exploratory CRISPR assays without overstating evidence across domains.
-
Trelagliptin succinate: Assay Workflow Guide
2026-09-30
This scenario-driven guide explains how Trelagliptin succinate (SKU A3889) can support reproducible cell viability, proliferation, cytotoxicity, and metabolic studies. It combines formulation guidance, model-specific concentration ranges, and analytical quality-control considerations with links to primary evidence.
-
Anlotinib hydrochloride Assay Workflows
2026-09-30
Build integrated angiogenesis experiments around Anlotinib hydrochloride, combining endothelial migration, capillary tube formation, viability, and receptor-phosphorylation readouts. The workflow distinguishes direct pathway inhibition from nonspecific toxicity while translating a clinically relevant case report into practical cancer research assay choices.
-
Mitoxantrone: A Transporter-Aware Framework
2026-09-29
Mitoxantrone research is more informative when cytotoxicity is interpreted alongside intracellular exposure and ABCG2-mediated efflux. This article develops a mechanistic framework for oncology and antiviral assays while connecting product handling to the 2024 marein–ABCG2 study.
-
Anlotinib Inhibits Angiogenesis via Three Kinases
2026-09-29
The reference study shows that anlotinib suppresses angiogenesis by jointly inhibiting VEGFR2, PDGFRβ, and FGFR1, with downstream attenuation of ERK signaling. Its combination of endothelial migration, tube formation, ex vivo vessel sprouting, and CAM assays provides a useful mechanistic framework for evaluating multi-target anti-angiogenic compounds.
-
Dual SMAD/Wnt Inhibition for iPSC-RGC Differentiation
2026-09-28
Chavali and colleagues developed a chemically defined differentiation strategy that combines dual SMAD and canonical Wnt inhibition to generate retinal ganglion cells (RGCs) from induced pluripotent stem cells (iPSCs) with improved yield and reproducibility. The approach produced RGC-enriched populations without genetic modification and incorporated Thy-1-based magnetic purification, providing a practical platform for glaucoma modeling and regenerative-ophthalmology research.
-
Temafloxacin Pharmacokinetics: Evidence and Implications
2026-09-28
This 1991 review integrates oral and intravenous temafloxacin data to explain its high bioavailability, prolonged elimination half-life, tissue distribution, and predominantly renal excretion. Its main contribution is a practical pharmacokinetic framework for interpreting dosing intervals and renal-function effects, while its findings remain specific to temafloxacin and the clinical evidence available at the time.
-
Citron OGD2 Links Iron Uptake to Canker Resistance
2026-09-27
The study identifies CmOGD2 as a contributor to citron resistance against citrus canker, linking iron acquisition and reactive oxygen species to a likely ferroptosis-related defense response. It also describes a regulatory circuit in which CmENO2 limits CmOGD2 expression through CmZAT10.1, while the Xanthomonas effector pthA4 appears to disrupt that restraint.
-
Thiazovivin (A5506) for Stem Cell Workflows
2026-09-26
Thiazovivin is a ROCK inhibitor used to support fibroblast reprogramming and human embryonic stem cell survival after trypsinization. This guide covers preparation and workflow controls; the dossier does not provide a cell-treatment dose, and the compound is for research use only—not diagnostic, clinical, or therapeutic use.
-
(R)-MG132: A Control for Proteasome Validation
2026-09-25
(R)-MG132 provides a stereochemical negative-control arm for testing whether a protein-abundance change depends on proteasome inhibition. In cervical cancer metabolism studies, it can help separate proteasome-related effects from changes in HNRNPU lactylation, PHGDH expression, and serine-pathway regulation.
-
Proteoform-Specific Drug Binding in Native Membranes
2026-09-25
Lutomski and colleagues present a native mass-spectrometry workflow that releases proteins and signaling complexes directly from retinal rod-disc membranes, preserving information about proteoforms and their interactions. The study links lipid modifications to G-protein assembly and shows that vardenafil and sildenafil have differential off-target interactions with retinal PDE6, illustrating why drug binding should be assessed in native membrane contexts.
-
PDGF-BB in Pulmonary Hypertension: From Mitogen to Model
2026-09-24
A mechanistic perspective on using murine recombinant PDGF-BB to establish controlled proliferation assays alongside emerging research into metabolic remodeling in pulmonary hypertension.
-
Deferiprone Workflows for Iron-Stress Research
2026-09-24
Use Deferiprone to create controlled iron-limitation models and track the resulting metabolic, inflammatory, and cell-fate responses. This guide translates enterocyte findings into practical assay choices while distinguishing established observations from research applications that require independent validation.
-
Ibrutinib (PCI-32765): BTK Research Guide
2026-09-23
Ibrutinib, also called PCI-32765, is an irreversible BTK inhibitor for research on B-cell receptor signaling and B-cell biology. The product dossier reports a BTK IC50 of 0.5 nM and describes in vitro CLL effects, while emphasizing that assay conditions and clinical use are outside the product’s research scope.
-
Firefly Luciferase mRNA: ARCA and 5-moUTP Guide
2026-09-23
Firefly Luciferase mRNA (ARCA, 5-moUTP) is a modified, capped reporter transcript for luciferase-based gene expression, cell viability, and imaging workflows. This guide separates product specifications from peer-reviewed evidence and defines practical limits for interpreting bioluminescent signals.